# Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter

> **NCT02649894** · NA · COMPLETED · sponsor: **C. R. Bard** · enrollment: 119 (actual)

## Conditions studied

- Malignant Pleural Effusion

## Interventions

- **DEVICE:** Active Comparator: Approved Uncoated PleurX Indwelling Pleural Catheter
- **DEVICE:** Experimental: Silver Nitrate Coated Indwelling Pleural Catheter (SNCIPC)

## Key facts

- **NCT ID:** NCT02649894
- **Lead sponsor:** C. R. Bard
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2018-04-18
- **Final completion:** 2018-04-18
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02649894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02649894, "Safety and Effectiveness of a New Pleural Catheter for Symptomatic, Recurrent, MPEs Versus Approved Pleural Catheter". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02649894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*